Hamilton Insurance Group, Ltd. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Hamilton Insurance Group, Ltd. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.91B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.33B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $1.57B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.23B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $64.03M | Mar 7, 2024 |
| FY2023 | Nov 30, 2021 | $1.33B | Mar 7, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $278.91M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $271.12M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $259.86M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $177.68M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $15.68M | Mar 7, 2024 |
| FY2023 | Nov 30, 2021 | $172.29M | Mar 7, 2024 |
| FY2023 | Dec 31, 2020 | $15.19M | Mar 7, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $842.35M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $759.30M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $283.16M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $190.93M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($33.91M) | Mar 7, 2024 |
| FY2023 | Nov 30, 2021 | $226.53M | Mar 7, 2024 |
| FY2023 | Dec 31, 2020 | ($20.77M) | Mar 7, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.57B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $7.80B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $6.67B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $5.82B | Mar 7, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.75B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $5.47B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $4.62B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $4.15B | Mar 7, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.82B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.33B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $2.05B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.66B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.75B | Mar 7, 2024 |
| FY2023 | Nov 30, 2021 | $1.79B | Mar 7, 2024 |
| FY2023 | Dec 31, 2020 | $1.66B | Mar 7, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | Feb 27, 2025 |
| FY2024 | Dec 31, 2023 | $0 | Feb 27, 2025 |
| FY2024 | Dec 31, 2022 | $0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $24.88M | Mar 7, 2024 |
| FY2023 | Nov 30, 2021 | $24.88M | Mar 7, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.69B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.17B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $801.37M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $547.35M | Mar 7, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.06B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $996.49M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $794.51M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.08B | Mar 7, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $149.74M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $149.95M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $149.83M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $149.72M | Mar 7, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 7, 2024 |
| FY2023 | Nov 30, 2021 | 1 | Mar 7, 2024 |
| FY2023 | Dec 31, 2020 | 0 | Mar 7, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 3 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 7, 2024 |
| FY2023 | Nov 30, 2021 | 1 | Mar 7, 2024 |
| FY2023 | Dec 31, 2020 | 0 | Mar 7, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 99.03M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 101.47M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 110.23M | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | 103.09M | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | 102.56M | Feb 27, 2025 |
| FY2023 | Nov 30, 2021 | 102.54M | Mar 7, 2024 |
| FY2023 | Nov 30, 2020 | 102.45M | Mar 7, 2024 |